Speaker illustration

Doctor Aya Tanaka

Takeda Pharmaceutical Company Limited, Fujisawa (Japan)

Purification of human iPSC-derived cardiomyocytes by HDAC inhibition through inducing apoptosis and cell arrest in non-cardiomyocytes

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Gene Therapy, Cell Therapy

Session: Basic Science Cardiac ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk